Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.89B |
| 2 |
Tesla
TSLA
|
+$788M |
| 3 |
Broadcom
AVGO
|
+$772M |
| 4 |
Amazon
AMZN
|
+$768M |
| 5 |
Workday
WDAY
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.5B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$898M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$565M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$441M |
| 5 |
Palo Alto Networks
PANW
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.36% |
| 2 | Consumer Discretionary | 2.24% |
| 3 | Healthcare | 1.2% |
| 4 | Financials | 1.17% |
| 5 | Communication Services | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
VanEck Commodity Strategy ETF
PIT
$310M
| $4.01M | ﹤0.01% |
87,178
+20,511
| +31% | +$1.04M |
|
3152
PUT
United Therapeutics
UTHR
$23.1B
| $4M | ﹤0.01% |
18,200
+7,000
| +63% | +$1.61M |
|
3153
Arvinas
ARVN
$572M
| $4M | ﹤0.01% |
97,217
+46,894
| +93% | +$1.1M |
|
3154
PUT
BioMarin Pharmaceuticals
BMRN
$12.4B
| $4M | ﹤0.01% |
41,500
-73,100
| -64% | -$6.47M |
|
3155
First Industrial Realty Trust
FR
$8.44B
| $4M | ﹤0.01% |
75,960
+24,708
| +48% | +$1.15M |
|
3156
BorgWarner
BWA
$13.9B
| $4M | ﹤0.01% |
111,578
+91,333
| +451% | +$3.26M |
|
3157
Moelis & Co
MC
$4.94B
| $4M | ﹤0.01% |
71,249
+38,411
| +117% | +$1.8M |
|
3158
10x Genomics
TXG
$6.61B
| $4M | ﹤0.01% |
71,451
+50,548
| +242% | +$2.2M |
|
3159
Avantis Responsible Emerging Markets Equity ETF
AVSE
$217M
| $4M | ﹤0.01% |
83,326
+23,062
| +38% | +$1.06M |
|
3160
iShares ESG Advanced High Yield Corporate Bond ETF
HYXF
$195M
| $3.99M | ﹤0.01% |
87,812
-96,738
| -52% | -$4.22M |
|
3161
MINISO
MNSO
$3.75B
| $3.99M | ﹤0.01% |
195,434
+136,342
| +231% | +$3.27M |
|
3162
PUT
Novavax
NVAX
$1.31B
| $3.99M | ﹤0.01% |
830,500
+24,000
| +3% | +$147K |
|
|
NARI
3163
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.99M | ﹤0.01% |
61,402
+41,147
| +203% | +$2.48M |
|
3164
LCI Industries
LCII
$2.65B
| $3.98M | ﹤0.01% |
31,687
+16,768
| +112% | +$1.93M |
|
3165
Invesco S&P International Developed Low Volatility ETF
IDLV
$348M
| $3.98M | ﹤0.01% |
141,403
-344,728
| -71% | -$9.18M |
|
3166
CALL
Camtek
CAMT
$7.25B
| $3.98M | ﹤0.01% |
57,400
+15,800
| +38% | +$962K |
|
3167
CALL
Axos Financial
AX
$5.68B
| $3.98M | ﹤0.01% |
72,900
+56,000
| +331% | +$2.34M |
|
3168
CALL
Liberty Media Series C
FWONK
$25.8B
| $3.97M | ﹤0.01% |
+62,900
| New | +$4.11M |
|
3169
CALL
GlobalFoundries
GFS
$29.6B
| $3.97M | ﹤0.01% |
65,500
-29,200
| -31% | -$1.62M |
|
3170
Ascendis Pharma A/S
ASND
$16.8B
| $3.96M | ﹤0.01% |
31,468
+6,751
| +27% | +$673K |
|
3171
Papa John's
PZZA
$806M
| $3.96M | ﹤0.01% |
51,962
-153,689
| -75% | -$10.5M |
|
3172
iShares World ex U.S. Carbon Transition Readiness Aware Active ETF
LCTD
$294M
| $3.96M | ﹤0.01% |
90,573
+64,016
| +241% | +$2.63M |
|
3173
PUT
Nasdaq
NDAQ
$52.9B
| $3.96M | ﹤0.01% |
68,100
+36,500
| +116% | +$1.92M |
|
3174
CALL
Exelixis
EXEL
$13.4B
| $3.96M | ﹤0.01% |
165,000
-46,100
| -22% | -$1M |
|
3175
Nokia
NOK
$52.3B
| $3.96M | ﹤0.01% |
1,156,690
+295,703
| +34% | +$1M |
|
Similar funds
Jane Street's Q4 2023 Portfolio in Review
As of Q4 2023, Jane Street held 10,187 positions worth $384B, up 24% from $309B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jane Street deployed $33.7B of net new capital in Q4 2023, opening 1,659 new positions and adding to 4,053 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, up from 2.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.5B trimmed.
- Jane Street's largest Q4 2023 buy was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
- Jane Street added most to Microsoft in Q4 2023, an estimated $1.89B increase.
- Jane Street's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.5B.
- Jane Street fully exited JPMorgan USD Emerging Markets Sovereign Bond ETF in Q4 2023, selling an estimated $121M.
- Jane Street's ten largest holdings make up 38% of its $384B portfolio in Q4 2023.
- Jane Street opened 1,659 new positions and closed 1,080 in Q4 2023.
- Jane Street's portfolio value rose 24% quarter-over-quarter to $384B.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.